NCT06685536 - A Long-term Follow-up Study in Participants Who Received CS-101 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 18, 2025

Primary Completion Date

July 31, 2039

Study Completion Date

July 31, 2039

Conditions

Beta-Thalassemia

Interventions

OTHER

Safety and efficacy assessments

Safety evaluations,disease-specific assessments,and assessments to monitor for long-term complications of autologous transplant

Trial Locations (1)

The First Affiliated Hospital of Guangxi Medical University, Nanning